Trial Profile
A Single-center, Open-label, Randomized, Two-way Crossover Study to Investigate the Effect of Multiple-dose Diltiazem on the Pharmacokinetics of a Single Dose of 25 mg ACT-541468 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Daridorexant (Primary) ; Diltiazem
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 04 Oct 2018 Results from two interaction studies (CTP: 280702 and CTP: 260030 ) published in the European Journal of Clinical Pharmacology.
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 22 Feb 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.